View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 17, 2019updated 22 Apr 2019 1:29pm

Scientist.com rolls out trial data analytics solution

Scientist.com has introduced a digital reporting solution, dubbed Trial Insights, to provider researchers with on-demand insights into clinical trials.

The analytics solution is the first direct service by the company, which operates an online marketplace for outsourced research.

Trial Insights is designed to simplify data generated during clinical trial, biomarker and medical diagnostic studies into an intuitive dashboard.

It curates publicly available data from information hubs, such as clinicaltrials.gov. The platform then customises the data based on the specific requirements of a researcher or research organisation.

Scientist.com chief business officer Mark Herbert said: “Our goal at Scientist.com is to help cure all diseases by 2050, and we believe solutions like Trial Insights, which greatly simplifies access to and reporting of clinical trial data, will get us one step closer to reaching that goal.”

The company noted that curating of data has become important with the rising velocity and variety. Furthermore, the emerging personalised medicine field also requires access to data.

According to Scientist.com, information offered through Trial Insights could aid pharmaceutical, biotechnology and contract research organisations in making research decisions.

This is expected to be helpful because clinical trial data is a key information source for research and clinical study planning.

Trial Insights is expected to facilitate continuous tracking of the latest advances across drugs, diseases, sponsors, investigators and medical devices.

Founded in 2007, Scientist.com runs private enterprise marketplaces for some of the major pharmaceutical companies.

The marketplace is said to simplify research and development (R&D) sourcing, and thus save time and money as well as mitigate risk.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU